Copyright
©The Author(s) 2022.
World J Clin Cases. May 6, 2022; 10(13): 4301-4313
Published online May 6, 2022. doi: 10.12998/wjcc.v10.i13.4301
Published online May 6, 2022. doi: 10.12998/wjcc.v10.i13.4301
Ref. | Gender/ages | Nation | Clinical symptoms | Size of tumor (cm) | Locations of tumor | Dura mater adhersion | Skull involvement | Treatment | Recurrence | Metastasis | Follow-up |
Scott et al[6], 1976 | M/39 | United Kingdom | Headache, nausea, vomit | NA | 4th Ventricle | N | N | PR | N | N | 13 d |
Smith and Davidson[7], 1981 | M/12 | United States | Headache, nausea, vomit, difficulty ambulating | 3.5 × 1.0 × 0.5 | Left cerebellum | Y | N | GTR | N | N | 13 mo |
Salcman et al[8], 1992 | F/28 | United States | Headache, slow speech, right limb weakness | 7.0 × 5.0 × 4.0 | Left parafacine region | N | N | GTR | Y | N | 10 mo |
Sato et al[9], 1993 | F/43 | Japan | Blurred vision, gait disturbance | NA | Pineal region | Y | N | PR, RT (60 Gy), chemotherapy | Y | Y | 36 mo |
Chaskis et al[10], 2002 | F/17 | Spain | Headache, status epilepticus | NA | Right frontal-parietal lobe | Y | N | GTR | Y | N | 16 mo |
González-Lois et al[11], 2002 | M/69 | Belgium | Headache, dizzy, behavior change | NA | Right frontal lobe | N | N | GTR | N | N | 1 mo |
Im et al[12], 2003 | M/43 | South Korea | Headache, nausea, vomit | 2.0 | Left parietal lobe | N | N | GTR, RT (59.4 Gy) | N | N | 36 mo |
Cummings et al[13], 2004 | M/63 | NA | Hearing loss, gait disturbance | 2.4 × 1.8 × 2.4 | Right jugular foramen, right CPA | N | NA | GTR | NA | NA | NA |
Sorimachi et al[15], 2008 | F/37 | Japan | Headache, nausea, vomit, upward gaze palsy | NA | Pineal region | N | N | GTR, | Y | N | NA |
O'Brien et al[14], 2008 | F/26 | Ireland | Headache, nausea, seizure | 2.5 | Left CPA | N | N | STR proton therapy | N | N | 12 mo |
Arpino et al[16], 2011 | F/54 | Ukraine | Headache, left ophthalmopegia | NA | Sellar and parasellar area | NA | Y | GTR | NA | NA | 12 mo |
Dulou et al[17], 2012 | F/70 | France | Behavior change, difficult in walk | NA | Left frontal lobe | N | N | GTR, preoperative RT (60 Gy) | Y | N | 10 mo |
Park et al[18], 2012 | F/21 | South Korea | Headache, right limb weakness, bilateral hearing loss, bilateral vision loss | 3.2 × 6.3 × 4.9 | Left lateral ventricle | N | N | GTR, RT (60.8 Gy) | NA | NA | 6 mo |
Qin et al[19], 2017 | F/41 | China | Headache, vomit | 3.0 × 3.0 × 3.0 | Left cerebellum | Y | Y | GTR, two stage of RT (56 Gy/50 Gy), chemotherapy | N | N | 20 mo |
Akakin et al[20], 2018 | F/75 | United States | Right limb weakness | NA | Left parafacine region | Y | N | GTR | Y | N | 2 mo |
Present case | M/52 | China | Headache, dizzy, nausea | 3.4 × 3.0 | Left cavernous sinus | Y | N | GTR, RT (45 Gy) | N | N | 12 mo |
Ref. | T1WI | T2WI | Enhanced MRI or other exams |
Scott et al[6], 1976 | NA | NA | NA |
Smith and Davidson[7], 1981 | NA | NA | NA |
Salcman et al[8], 1992 | Well-defined, hyperintensity | Homogeneous hyperintensity | NA |
Sato et al[9], 1993 | NA | NA | NA |
Chaskis et al[10], 2002 | Hypointensity | NA | Heterogeneous enhancement |
González-Lois et al[11], 2002 | NA | NA | Significantly homogeneous enhancement |
Im et al[12], 2003 | Unclear-defined, hypointensity | Hyperintensity | Homogeneously well enhanced |
Cummings et al[13], 2004 | NA | NA | Heterogeneous enhancement |
Sorimachi et al[15], 2008 | Mixed signal intensity, hyperintensity (hemorrhage) | NA | Heterogeneous enhancement |
O'Brien et al[14], 2008 | Hypointensity | Hyperintensity | NA |
Arpino et al[16], 2011 | Hypointensity | Hyperintensity | Heterogeneously peripheral enhancement |
Dulou et al[17], 2012 | NA | Hyperintensity, peritumor edema | Heterogeneously ring-like enhancement |
Park et al[18], 2012 | Homogeneous iso-intensity | Heterogeneous hyperintensity, Peritumor edema | Heterogeneously lobulated enhancement |
Qin et al[19], 2017 | NA | NA | NA |
Akakin et al[20], 2018 | NA | Heterogeneous hyperintensity | Heterogeneously rim-like enhancement, DWI showed intratumor calcification |
Present case | Homogeneous hypointensity | Heterogeneous hyperintensity | Heterogeneously well enhanced |
- Citation: Zhu ZY, Wang YB, Li HY, Wu XM. Primary intracranial extraskeletal myxoid chondrosarcoma: A case report and review of literature. World J Clin Cases 2022; 10(13): 4301-4313
- URL: https://www.wjgnet.com/2307-8960/full/v10/i13/4301.htm
- DOI: https://dx.doi.org/10.12998/wjcc.v10.i13.4301